Home  >  News
Msc_Jun22 Advertisement
you can get e-magazine links on WhatsApp. Click here
Therma Bright seeks Health Canada approval for AcuVid Covid-19 Rapid Antigen Saliva Test for PoC  June 25, 2022
EMA committee recommends approval of argenx’s efgartigimod to generalized myasthenia gravis  June 25, 2022
EMA committee recommends expanded conditional marketing approval for Novavax Covid-19 vaccine, Nuvaxovid for adolescents aged 12 through 17  June 25, 2022
IONIQ Sciences introduces next-generation early-stage cancer detection platform, LUNA3  June 25, 2022
FoCus phase III trial of ALXN1840 shows rapid and sustained improvement in copper mobilisation from tissues, potentially closing treatment gaps for Wilson disease community  June 25, 2022
China NMPA approves intravenous formulation of Cresemba to treat invasive aspergillosis and invasive mucormycosis  June 25, 2022
US FDA releases Action Plan for Rare Neurodegenerative Diseases including ALS  June 25, 2022
Sanofi-GSK first to report a successful efficacy study against Omicron with Covid-19 Beta-containing vaccine  June 25, 2022
Taiwan FDA grants emergency use authorization to Novavax' Nuvaxovid Covid-19 vaccine for use in individuals aged 18 and over  June 25, 2022
Merck’s Keytruda gets European approval as adjuvant treatment for adult and adolescent patients with stage IIB or IIC melanoma following complete resection  June 25, 2022
Copyright © 2016 Saffron Media Pvt. Ltd |